1. Screening and Production of Arylsulfatases for Target Therapy with Etoposide 4′-Sulfate, an Antitumor Prodrug
- Author
-
Satoshi Yamamoto, Toshikazu Oki, Tomokazu Ueki, Yosuke Sawada, Yasuo Fukagawa, Koji Tomita, and Takeshi Ohnuma
- Subjects
Molecular Sequence Data ,Antineoplastic Agents ,Sulfuric Acid Esters ,Applied Microbiology and Biotechnology ,Biochemistry ,Streptomyces ,Analytical Chemistry ,Microbiology ,chemistry.chemical_compound ,medicine ,Streptomyces griseorubiginosus ,Prodrugs ,Sulfate ,Molecular Biology ,Etoposide ,Arylsulfatases ,biology ,Streptomycetaceae ,Organic Chemistry ,General Medicine ,biology.organism_classification ,Carbohydrate Sequence ,chemistry ,Fermentation ,Microscopy, Electron, Scanning ,biology.protein ,Actinomycetales ,Arylsulfatase ,Biotechnology ,medicine.drug - Abstract
Two arylsulfatase-producing streptomycetes that desulfated etoposide 4'-sulfate were isolated from soil samples. Taxonomical study identified one soil isolate as Streptomyces griseorubiginosus S980-14 (Es-1 arylsulfatase producer), while the other was considered new and tentatively designated Streptomyces sp. T109-3 (Es-2 arylsulfatase producer). Both strains produced extracellular arylsulfatase activities, provided that cultivation media were prepared with distilled water. Unlike the two known types of arylsulfatases, which had significant activity on p-nitrophenyl sulfate but none on etoposide 4'-sulfate, the crude streptomycete arylsulfatases efficiently desulfated etoposide 4'-sulfate and p-nitrophenyl sulfate, which supports the establishment of a new type of arylsulfatases.
- Published
- 1995
- Full Text
- View/download PDF